| CANDRIAM EQUITIES L BIOTECHNOLOGY, V - CAPITALISATION |
    
|
|
| DAX | 25.159,25 | 270,69 | 1,09% |
| TecDax | 4.058,08 | 21,99 | 0,54% |
| MDAX | 32.677,04 | 568,77 | 1,77% |
| Dow Jones (EOD) | 50.579,70 | 294,04 | 0,58% |
| Nasdaq 100 | 29.481,64 | 124,37 | 0,42% |
| S & P 500 (EOD) | 7.473,47 | 27,75 | 0,37% |
| SMI | 13.503,21 | 56,78 | 0,42% |
|
| EUR/US$ | 1,1639 | 0,00 | 0,30% |
| EUR/Yen | 184,9870 | 0,27 | 0,15% |
| EUR/CHF | 0,9100 | -0,00 | -0,10% |
| EUR/Brit. Pfund | 0,8630 | -0,00 | -0,08% |
| Yen/US$ | 0,0063 | 0,00 | 0,02% |
| CHF/US$ | 1,2790 | 0,00 | 0,06% |
|
| baha Brent Indication | 96,12 | -4,62 | -4,58% |
| Gold | 4.564,16 | 55,88 | 1,24% |
| Silber | 77,91 | 2,39 | 3,16% |
| Platin | 1.952,38 | 22,02 | 1,14% |
| |
|
|
3.009,92 
